Bridgeway Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bridgeway Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,000	Closed	-$246K	–	1481
2016 Q3	$246K	Hold	20,000	–	–	﹤0.01%	1285
2016 Q2	$219K	Hold	20,000	–	–	﹤0.01%	1290
2016 Q1	$219K	Hold	20,000	–	–	﹤0.01%	1288
2015 Q4	$346K	Sell	20,000 -500	-2%	-$8.96K	0.01%	1170
2015 Q3	$407K	Sell	20,500 -20,000	-49%	-$459K	0.01%	1126
2015 Q2	$665K	Buy	40,500 +500	+1%	+$8.67K	0.01%	942
2015 Q1	$622K	Sell	40,000 -90,500	-69%	-$1.4M	0.01%	996
2014 Q4	$1.86M	Hold	130,500	–	–	0.04%	541
2014 Q3	$848K	Hold	130,500	–	–	0.02%	819
2014 Q2	$900K	Hold	130,500	–	–	0.02%	813
2014 Q1	$933K	Hold	130,500	–	–	0.03%	785
2013 Q4	$1.23M	Hold	130,500	–	–	0.04%	672
2013 Q3	$814K	Buy	130,500 +24,700	+23%	+$154K	0.03%	812
2013 Q2	$696K	Buy	+105,800	New	+$839K	0.03%	795

Other funds holding SCMP

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

Bridgeway Capital Management's SCMP Position: Q4 2016 in Review

Bridgeway Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2016, closing a stake of 20,000 shares — an estimated $246K sold.

Bridgeway Capital Management first reported a position in SCMP in Q2 2013 and held it in 14 quarters. The position peaked at $1.86M in Q4 2014. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

Bridgeway Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Bridgeway Capital Management sold 20,000 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $246K.
Bridgeway Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
Bridgeway Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.86M in Q4 2014.
165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on Bridgeway Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.